Nikkei Reports Meta Has Met Complied With Japanese Registration Requirement
https://asia.nikkei.com/Business/Technology/Facebook-parent-Meta-TikTok-meet-deadline-to-register-in-Japan
CORRECTION: XPeng Q2 EPS $(0.43) Down From $(0.21) YoY, Sales $1.11B Beat $1.06B Estimate
XPeng (NYSE:XPEV) reported quarterly losses of $(0.43) per share. This is a 104.76 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.11 billion
Waitr Holdings Inc. Announces Partnership With FoodBoss Food Delivery Search Engine
First Partnership After "Deliver Anything" Rebrand
ASAP, the on-demand delivery brand for Waitr Holdings Inc. (NASDAQ:WTRH), has announced a new partnership with FoodBoss, an industry leading online food
MDJM Acquires Fernie Castle Hotel
MDJM LTD (NASDAQ:MDJH) (the "Company" or "MDJM"), an integrated real estate services company in China, today announced that its wholly owned subsidiary in United Kingdom, MD Local Global
Concrete Pumping Holdings Acquires Coastal Carolina Pumping
– Acquisition Expands Company's Presence in North Carolina, South Carolina and Florida Markets –
– Strengthens Recent Greenfield Expansion in Washington D.C. –
DENVER, Aug. 23, 2022
Synlogic Granted FDA Fast Track Designation For SYNB1353 For Treatment Of Homocystinuria (HCU)
CAMBRIDGE, Mass., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to
Foghorn Therapeutics Announces FDA Has Placed A Clinical Hold On Phase I Dose Escalation Study Of FHD-286
Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical stage biotechnology company pioneering a new class of medicines that modulate gene expression through selectively targeting the chromatin regulatory system,
Macy’s Q2 EPS $1.00 Beats $0.85 Estimate, Sales $5.60B Beat $5.49B Estimate
Macy's (NYSE:M) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.85 by 17.65 percent. This is a 22.48 percent decrease over earnings of $1.29 per share from the same period
Jianpu Technology Q2 Sales $39.6M, Up 33.9% YoY
Total revenues for the second quarter of 2022 increased by 33.9% to RMB265.1 million (US$39.6 million) from RMB198.0 million in the same period of 2021.
Medtronic Reaffirms FY23 Guidance
Guidance
The company today reiterated its revenue growth and EPS guidance ranges for fiscal year 2023.
The company continues to expect organic revenue growth in its fiscal year 2023 in the range